Ken Ando Selected Research

Aarskog Syndrome

1/2010	Proline-rich domain plays a crucial role in extracellular stimuli-responsive translocation of a Cdc42 guanine nucleotide exchange factor, FGD1.
4/2008	Novel insights into FGD3, a putative GEF for Cdc42, that undergoes SCF(FWD1/beta-TrCP)-mediated proteasomal degradation analogous to that of its homologue FGD1 but regulates cell morphology and motility differently from FGD1.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Ken Ando Research Topics

Disease

29	Uterine Cervical Neoplasms (Cancer of the Cervix) 07/2022 - 12/2012
28	Neoplasms (Cancer) 07/2022 - 12/2012
8	Squamous Cell Carcinoma (Epidermoid Carcinoma) 03/2022 - 01/2014
3	Neoplasm Metastasis (Metastasis) 01/2022 - 01/2016
3	Adenocarcinoma 05/2021 - 06/2014
2	Carcinoma (Carcinomatosis) 05/2022 - 02/2017
2	Disease Progression 08/2021 - 08/2018
2	Mucositis 01/2018 - 02/2017
2	Hepatocellular Carcinoma (Hepatoma) 08/2015 - 12/2012
2	Hypoxia (Hypoxemia) 07/2015 - 03/2009
2	Aarskog Syndrome 01/2010 - 04/2008
1	Breast Neoplasms (Breast Cancer) 05/2022
1	Lymphadenopathy 03/2022
1	Fistula 04/2021
1	Rectovaginal Fistula 04/2021
1	Lymphatic Metastasis 06/2019
1	Hemorrhage 09/2018
1	Hypopharyngeal Neoplasms 01/2018
1	Laryngeal Neoplasms (Laryngeal Cancer) 02/2017
1	Fibrosarcoma 11/2015
1	Adenocarcinoma of Lung 07/2015
1	Rectal Neoplasms (Rectal Cancer) 01/2014
1	Leukopenia 05/2013
1	Thrombocytopenia (Thrombopenia) 05/2013
1	Liver Neoplasms (Liver Cancer) 12/2012
1	Leukemia 05/2010
1	Endotoxemia 05/2010
1	Ischemia 03/2009
1	Cholestasis 03/2009

Drug/Important Bio-Agent (IBA)

6	CarbonIBA 01/2022 - 12/2012
4	IonsIBA 01/2022 - 11/2015
3	Biomarkers (Surrogate Marker)IBA 05/2022 - 06/2021
3	Cisplatin (Platino)FDA LinkGeneric 06/2019 - 05/2013
2	Immune Checkpoint InhibitorsIBA 05/2022 - 06/2021
2	Cyclin-Dependent Kinase Inhibitor p16IBA 08/2015 - 12/2012
2	Proteins (Proteins, Gene)FDA Link 08/2015 - 07/2015
2	Biological ProductsIBA 04/2013 - 05/2010
2	Guanine Nucleotide Exchange Factors (Guanine Nucleotide Exchange Factor)IBA 01/2010 - 04/2008
2	Proteasome Endopeptidase Complex (Proteasome)IBA 01/2010 - 04/2008
2	SKP Cullin F-Box Protein LigasesIBA 01/2010 - 04/2008
2	Serine (L-Serine)FDA Link 01/2010 - 04/2008
1	SiliconesIBA 05/2022
1	AntigensIBA 05/2022
1	SolutionsIBA 05/2022
1	Hydrogen Peroxide (Hydroperoxide)FDA LinkGeneric 05/2022
1	squamous cell carcinoma-related antigenIBA 08/2021
1	B7-H1 AntigenIBA 06/2021
1	Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA 04/2021
1	Monoclonal AntibodiesIBA 04/2021
1	Bevacizumab (Avastin)FDA Link 04/2021
1	Granulocyte Colony-Stimulating Factor (G-CSF)IBA 01/2021
1	2- (4- (2- (5- (1- (3,5- dichloropyridin- 4- yl)ethoxy)- 1H- indazol- 3yl)vinyl)- 1H- pyrazol- 1- yl)ethanolIBA 09/2019
1	Dihydrotachysterol (AT 10)IBA 09/2018
1	EnzymesIBA 01/2018
1	CalreticulinIBA 07/2017
1	Proton Pump InhibitorsIBA 02/2017
1	Fibrinogen (Factor I)FDA Link 11/2015
1	Cyclin-Dependent Kinases (cdk Proteins)IBA 08/2015
1	temsirolimus FDA Link 07/2015
1	TOR Serine-Threonine KinasesIBA 07/2015
1	Neoplasm Antigens (Tumor Antigens)IBA 05/2015
1	HMGB1 Protein (HMG1)IBA 05/2015
1	AntibodiesIBA 01/2014
1	Immunoglobulin G (IgG)IBA 01/2014
1	HLA Antigens (Human Leukocyte Antigens)IBA 01/2014
1	CytokinesIBA 01/2014
1	NF-kappa B (NF-kB)IBA 05/2010
1	Peptides (Polypeptides)IBA 05/2010
1	LipopolysaccharidesIBA 05/2010
1	EndotoxinsIBA 05/2010
1	CarbohydratesIBA 05/2010
1	Isoleucine (L-Isoleucine)FDA Link 01/2010
1	Proline (L-Proline)FDA Link 01/2010
1	Member 11 Subfamily B ATP Binding Cassette TransporterIBA 03/2009
1	Bile Acids and Salts (Bile Acids)IBA 03/2009
1	p38 Mitogen-Activated Protein KinasesIBA 03/2009
1	beta-Transducin Repeat-Containing ProteinsIBA 04/2008

Therapy/Procedure

29	Radiotherapy 07/2022 - 12/2012
14	Brachytherapy 05/2022 - 01/2014
14	Heavy Ion Radiotherapy 01/2022 - 12/2012
7	Therapeutics 03/2022 - 12/2012
5	Chemoradiotherapy 05/2022 - 05/2013
3	Immunotherapy 01/2022 - 01/2016
2	Aftercare (After-Treatment) 07/2022 - 09/2018
1	Hysterectomy 03/2021
1	Induced Hyperthermia (Thermotherapy) 01/2018
1	Conformal Radiotherapy 07/2017
1	Re-Irradiation 04/2013